Header Logo

Connection

Maria Paximadis to South Africa

Back to Details
This is a "connection" page, showing publications Maria Paximadis has written about South Africa.
Maria Paximadis
Connection Strength
0,538
South Africa
  1. Interleukin-8 genetic diversity, haplotype structure and production differ in two ethnically distinct South African populations. Cytokine. 2021 07; 143:155489.
    View in: PubMed
    Score: 0,076
  2. RICH2 is implicated in viraemic control of HIV-1 in black South African individuals. Infect Genet Evol. 2017 04; 49:78-87.
    View in: PubMed
    Score: 0,057
  3. Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population. Hum Immunol. 2012 Jan; 73(1):80-92.
    View in: PubMed
    Score: 0,039
  4. Identification of new variants within the two functional genes CCL3 and CCL3L encoding the CCL3 (MIP-1alpha) chemokine: implications for HIV-1 infection. Int J Immunogenet. 2009 Feb; 36(1):21-32.
    View in: PubMed
    Score: 0,032
  5. FCGR3A gene duplication, Fc?RIIb-232TT and Fc?RIIIb-HNA1a associate with an increased risk of vertical acquisition of HIV-1. PLoS One. 2022; 17(9):e0273933.
    View in: PubMed
    Score: 0,021
  6. Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants. Clin Infect Dis. 2022 03 23; 74(6):1047-1054.
    View in: PubMed
    Score: 0,020
  7. Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers. Front Immunol. 2021; 12:781263.
    View in: PubMed
    Score: 0,020
  8. Genome organization of Tobacco leaf curl Zimbabwe virus, a new, distinct monopartite begomovirus associated with subgenomic defective DNA molecules. J Gen Virol. 2001 Dec; 82(Pt 12):3091-3097.
    View in: PubMed
    Score: 0,020
  9. Quantifying the Dynamics of HIV Decline in Perinatally Infected Neonates on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2020 10 01; 85(2):209-218.
    View in: PubMed
    Score: 0,018
  10. Human leukocyte antigen class I (A, B, C) and class II (DPB1, DQB1, DRB1) allele and haplotype variation in Black South African individuals. Hum Immunol. 2020 Jan; 81(1):6-7.
    View in: PubMed
    Score: 0,017
  11. Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans. Clin Immunol. 2019 08; 205:16-24.
    View in: PubMed
    Score: 0,017
  12. The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progression. Genes Immun. 2019 11; 20(8):651-659.
    View in: PubMed
    Score: 0,016
  13. Living donor liver transplant from an HIV-positive mother to her HIV-negative child: opening up new therapeutic options. AIDS. 2018 10 23; 32(16):F13-F19.
    View in: PubMed
    Score: 0,016
  14. Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations. Hum Immunol. 2017 Jul - Aug; 78(7-8):503-509.
    View in: PubMed
    Score: 0,015
  15. CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships. Immunology. 2017 08; 151(4):464-473.
    View in: PubMed
    Score: 0,015
  16. Human leukocyte antigen class I (A, B and C) allele and haplotype variation in a South African Indian population. Hum Immunol. 2017 Jul - Aug; 78(7-8):468-470.
    View in: PubMed
    Score: 0,014
  17. Human leukocyte antigen class I (A, B and C) allele and haplotype variation in a South African Mixed ancestry population. Hum Immunol. 2017 May - Jun; 78(5-6):399-400.
    View in: PubMed
    Score: 0,014
  18. CXCR6 gene characterization in two ethnically distinct South African populations and association with viraemic disease control in HIV-1-infected black South African individuals. Clin Immunol. 2017 07; 180:69-79.
    View in: PubMed
    Score: 0,014
  19. Maternal human leukocyte antigen-G (HLA-G) genetic variants associate with in utero mother-to-child transmission of HIV-1 in Black South Africans. Infect Genet Evol. 2015 Mar; 30:147-158.
    View in: PubMed
    Score: 0,012
  20. Frequencies of immune hypersensitivity reaction-associated HLA class I alleles in healthy South African Indian and mixed ancestry populations determined by a novel real-time PCR assay. Tissue Antigens. 2014 Oct; 84(4):389-97.
    View in: PubMed
    Score: 0,012
  21. Comparison of a quantitative Real-Time PCR assay and droplet digital PCR for copy number analysis of the CCL4L genes. Infect Genet Evol. 2014 Jul; 25:28-35.
    View in: PubMed
    Score: 0,012
  22. Genetic variability in markers of HLA-C expression in two diverse South African populations. PLoS One. 2013; 8(7):e67780.
    View in: PubMed
    Score: 0,011
  23. Contribution of variable CCL3L copy number to CCL3 protein production in two ethnically divergent South African populations. Infect Genet Evol. 2013 Mar; 14:347-56.
    View in: PubMed
    Score: 0,011
  24. Marked differences in CCR5 expression and activation levels in two South African populations. Immunology. 2012 Aug; 136(4):397-407.
    View in: PubMed
    Score: 0,010
  25. Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype. J Acquir Immune Defic Syndr. 2011 Jul 01; 57(3):181-9.
    View in: PubMed
    Score: 0,010
  26. Identification of predominant culturable vaginal Lactobacillus species and associated bacteriophages from women with and without vaginal discharge syndrome in South Africa. J Med Microbiol. 2011 Feb; 60(Pt 2):180-183.
    View in: PubMed
    Score: 0,009
  27. Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations. Infect Genet Evol. 2010 May; 10(4):487-94.
    View in: PubMed
    Score: 0,009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.